The DDS®-1 strain of Lactobacillus acidophilus has been shown, either alone or in combination, to alleviate symptoms of lactose intolerance and Irritable Bowel Syndrome, assist in the prevention of Traveler’s Diarrhea, improve urinary tract health, shorten resolution time and severity of acute respiratory infections, reduce scoring of atopic dermatitis and positively modulate gastrointestinal ecology.
To review the clinical and laboratory evidence supporting this strain, as well as learn more about the strain’s history and benefits across the age spectrum, please download the whitepaper.
